Pharma channel feed – Endpoints News

Pharma channel feed

Roche tacks on another Xofluza indication as flu season meets pandemic

5 years ago

A poll suggests vaccine data boosted Pfizer's public image, but other data point to long road ahead

5 years ago

Alnylam gets the green light from the FDA for drug #3 — and CEO John Maraganore is ready to roll

5 years ago

With only weeks left in his presidency, Trump makes a final, long-shot bid to remake US drug pricing

5 years ago

J&J joins Bristol Myers Squibb with $100M commitment to diversity efforts

5 years ago

Pharma lobbyist and longtime Biden loyalist Steve Ricchetti joins the inner circle headed to the White House as drug pricing remains a hot topic

5 years ago

Analysts poured cold water, but FDA gives a fast-pass for Sanofi's new Pompe disease drug

5 years ago

Bristol Myers Squibb Foundation launches program to tackle diversity problem in clinical trials

5 years ago

Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics

5 years ago

French health products agency yanked into legal battle over birth defects caused by Sanofi's Depakine

5 years ago

Government gears for unprecedented challenge of Eli Lilly antibody rollout as efficacy questions linger

5 years ago

Bristol Myers posts another win for their Otezla competitor, this time with PhII data in psoriatic arthritis

5 years ago

Endo Pharmaceuticals chops 560 jobs to refocus on cellulite drug launch

5 years ago

An election night bereft of answers quells biopharma's 'worst-case' fears — analysts

5 years ago

Prevail and Alector both claim victory in arbitration over scientist-CEO, telling divergent tales of confidential hearings

5 years ago

Small cap immunotherapy player Ziopharm faces an activist attack, rebukes call for board seats

5 years ago

Novo Nordisk quietly nabs a rare 'breakthrough' status in NASH for its cash cow

5 years ago

Sanofi teams up with Merck to pair Keytruda with a next-gen IL-2 candidate from the Synthorx buyout

5 years ago

Once rejected, Kala's dry eye drug now gains entry to a field where Novartis is grooming its own blockbuster

5 years ago

Indivior's Shaun Thaxter heads to prison, joining Insys' John Kapoor among jailed opioid execs

5 years ago

FDA anoints Gilead's remdesivir as the Covid-19 treatment winner, handing down full approval — despite some deep skepticism

5 years ago

Roche finds a home for a new, $500M manufacturing logistics hub, promising 500 jobs

5 years ago

What about the German negotiation model? Biden steers drug pricing debate to a showdown

5 years ago

Super-secretive anti-aging biotech Calico tees up the first visible clinical trial of an experimental drug. And it’s for cancer?

5 years ago

First page Previous page 249 250 251252253 254 255 Next page Last page